Abiopharma

iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results

All the suspending conditions were fulfilled for the sale of the remaining shares (50%) in Tzafon HaYarkon Tel Aviv Ltd.

Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040

Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026

The Marriott Vacation Clubs Launches Inner Circle, New Platform Redefining Owner Experiences

Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial

Net Asset Value(s)

Immediate Report